Published in Vaccine Weekly, September 29th, 1997
The study showed that immunizations with the HGP-30 vaccine coupled to KLH were safe in AIDS patients. Based upon these results, Cel-Sci Corp. and AIDS ReSEARCH Alliance have intended to evaluate the HGP-30 vaccine together with sargramostim, a recombinant human granulocyte macrophage-colony stimulating factor (GM-CSF), supplied by Immunex Corp., Seattle, Washington. It is hoped that the combination of these drugs will enhance the patients' immune responses to the HGP-30...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly